{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:41:10Z","timestamp":1789940470871,"version":"4.0.1"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T00:00:00Z","timestamp":1292544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s10741-010-9211-5","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T15:24:34Z","timestamp":1292513074000},"page":"45-64","source":"Crossref","is-referenced-by-count":46,"title":["Chronic Chagas\u2019 heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine"],"prefix":"10.1007","volume":"17","author":[{"given":"Silvia Gilka","family":"Mu\u00f1oz-Saravia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathrin","family":"Haberland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Wallukat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Schimke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,17]]},"reference":[{"key":"9211_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0891-5520(20)30574-2","volume":"8","author":"A Prata","year":"1994","unstructured":"Prata A (1994) Chagas\u2019 disease. Infect Dis Clin North Am 8:61\u201376","journal-title":"Infect Dis Clin North Am"},{"key":"9211_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","volume":"1","author":"A Prata","year":"2001","unstructured":"Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1:92\u2013100","journal-title":"Lancet Infect Dis"},{"key":"9211_CR3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/pgmj.2006.047357","volume":"82","author":"AR Teixeira","year":"2006","unstructured":"Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA (2006) Chagas disease. Posgrad Med 82:788\u2013798","journal-title":"Posgrad Med"},{"key":"9211_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1590\/S0074-02762006000500001","volume":"101","author":"AR Teixeira","year":"2006","unstructured":"Teixeira AR, Nascimento RJ, Sturm NR (2006) Evolution and pathology in Chagas disease\u2014a review. Mem Inst Oswaldo Cruz 101:463\u2013491","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR5","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","volume":"115","author":"JA Marin-Neto","year":"2007","unstructured":"Marin-Neto JA, Cunha-Nerto E, Maciel BC, Simoes MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109\u20131123","journal-title":"Circulation"},{"key":"9211_CR6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1590\/S0074-02762003000500001","volume":"98","author":"A Moncayo","year":"2003","unstructured":"Moncayo A (2003) Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 98:577\u2013591","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3201\/eid1304.061002","volume":"13","author":"PL Dorn","year":"2007","unstructured":"Dorn PL, Perniciaro L, Yabsley MJ, Roelling DM, Balsamo G, Diaz J, Wesson D (2007) Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg Infect Dis 13:605\u2013607","journal-title":"Emerg Infect Dis"},{"key":"9211_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1590\/S0074-02762005000800002","volume":"100","author":"JC Dias","year":"2005","unstructured":"Dias JC, Schofield CJ, Machado EM, Fernandes AJ (2005) Ticks, ivermectin, and experimental Chagas disease. Mem Inst Oswldo Cruz 100:829\u2013832","journal-title":"Mem Inst Oswldo Cruz"},{"key":"9211_CR9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1590\/S0074-02762002000500002","volume":"97","author":"JC Dias","year":"2002","unstructured":"Dias JC, Silveira AC, Schofield CJ (2002) The impact of Chagas disease control in Latin America\u2014a review. Mem Inst Oswaldo Cruz 97:603\u2013612","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1179\/136485906X112248","volume":"100","author":"A Moncayo","year":"2006","unstructured":"Moncayo A, Ortiz Yanine MI (2006) An update on Chagas disease (human American trypanosomiasis. Ann Trop Med Parasitol 100:663\u2013677","journal-title":"Ann Trop Med Parasitol"},{"key":"9211_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1590\/S0037-86822008000200012","volume":"41","author":"JC Dias","year":"2008","unstructured":"Dias JC, Prata A, Correia D (2008) Problems and perspectives for Chagas disease control: in search of realistic analysis. Rev Soc Bras Med Trop 41:193\u2013196","journal-title":"Rev Soc Bras Med Trop"},{"key":"9211_CR12","unstructured":"Salvatella R (2007, July 6) Achievments in controlling Chagas disease in Latin America. In: Conference Geneva (WHO)"},{"key":"9211_CR13","first-page":"49","volume-title":"Chagas\u2019 disease (American trypanosomiasis): its impact on transfusion and clinical medicine","author":"JC Dias","year":"2001","unstructured":"Dias JC (2001) Epidemiology of Chagas\u2019 disease. In: Wendel S, Brener Z, Camargo ME, Rassi A (eds) Chagas\u2019 disease (American trypanosomiasis): its impact on transfusion and clinical medicine. Sociedade Brasileira de Hematologia e Hemoterapia, Sao Paulo, pp 49\u201380"},{"key":"9211_CR14","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/605091","volume":"49","author":"C Bern","year":"2009","unstructured":"Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49:e52\u2013e54","journal-title":"Clin Infect Dis"},{"key":"9211_CR15","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/eurheartj\/ehn424","volume":"29","author":"RA Guerri-Guttenberg","year":"2008","unstructured":"Guerri-Guttenberg RA, Grana DR, Ambrosio G, Milei J (2008) Chagas cardiomyopathy: Europe is not spared!. Eur Heart J 29:2587\u20132591","journal-title":"Eur Heart J"},{"key":"9211_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","volume":"115","author":"GA Schmunis","year":"2010","unstructured":"Schmunis GA, Yadon ZE (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115:14\u201321","journal-title":"Acta Trop"},{"key":"9211_CR17","first-page":"125","volume":"59","author":"GA Schmunis","year":"1999","unstructured":"Schmunis GA (1999) Risk of Chagas disease through transfusions in the Americans. Medicina (B Aires) 59:125\u2013134","journal-title":"Medicina (B Aires)"},{"issue":"suppl 1","key":"9211_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1590\/S0074-02761999000700011","volume":"94","author":"JCP Dias","year":"1999","unstructured":"Dias JCP, Schofield CJ (1999) The evolution of Chagas disease (American trypanosomiasis) control after 90\u00a0years since Carlos Chagas discovery. Men Inst Oswaldo Cruz 94(suppl 1):103\u2013121","journal-title":"Men Inst Oswaldo Cruz"},{"key":"9211_CR19","first-page":"141","volume":"56","author":"Centers for Disease Control, Prevention (CDC)","year":"2007","unstructured":"Centers for Disease Control, Prevention (CDC) (2007) Blood donor screening for Chagas disease-United States, 2006\u20132007. MMWR Morb Mortal Wkly Rep 56:141\u2013143","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9211_CR20","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/j.1537-2995.2008.01789.x","volume":"48","author":"M Piron","year":"2008","unstructured":"Piron M, Verges M, Munoz J, Casamitjana N, Sanz S, Maym\u00f3 RM, Hern\u00e1ndez JM, Puig L, Port\u00fas M, Gasc\u00f3n J, Sauleda S (2008) Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion 48:1862\u20131868","journal-title":"Transfusion"},{"key":"9211_CR21","first-page":"5","volume":"17","author":"RA Guerri-Guttenberg","year":"2009","unstructured":"Guerri-Guttenberg RA, Ciannameo A, Di Girolamo C, Milei JJ (2009) Chagas disease: an emerging public health problem in Italy? Infez Med 17:5\u201313","journal-title":"Infez Med"},{"key":"9211_CR22","first-page":"131","volume":"70","author":"Soci\u00e9t\u00e9 de pathologie exotique","year":"2010","unstructured":"Soci\u00e9t\u00e9 de pathologie exotique (2010) Chagas disease. American trypanosomiasis. Recommendation for non-endemic zones. Med Trop (Mars) 70:131\u2013132","journal-title":"Med Trop (Mars)"},{"key":"9211_CR23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0277-9536(93)90285-C","volume":"37","author":"E Azogue","year":"1993","unstructured":"Azogue E (1993) Women and congenital Chagas\u2019 disease in Santa Cruz, Bolivia: epidemiological and sociocultural aspects. Soc Sci Med 37:503\u2013511","journal-title":"Soc Sci Med"},{"key":"9211_CR24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4269\/ajtmh.2006.75.1078","volume":"75","author":"C Riera","year":"2006","unstructured":"Riera C, Guarro A, Kassab HE, Jorba JM, Castro M, Angrill R, G\u00e1llego M, Fisa R, Martin C, Lobato A, Port\u00fas M (2006) Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg 75:1078\u20131081","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0074-02762004000100001","volume":"99","author":"AM Macedo","year":"2004","unstructured":"Macedo AM, Machado CR, Oliveira RP, Pena SD (2004) Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz 99:1\u201312","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR26","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1590\/S0102-311X2007001000002","volume":"23","author":"S Manoel-Caetano Fda","year":"2007","unstructured":"Manoel-Caetano Fda S, Silva AE (2007) Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease. Cad Saude Publica 23:2263\u20132274","journal-title":"Cad Saude Publica"},{"key":"9211_CR27","unstructured":"Torrico F, Castro M (2002) Enfermedad de Chagas. In: Medicina tropical, CD-Rom, ITGPRESS; ISBN 90-76070-237"},{"key":"9211_CR28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4269\/ajtmh.1996.54.526","volume":"54","author":"DE Ochs","year":"1996","unstructured":"Ochs DE, Hnilica VS, Moser DR, Smith JK, Kirchhoff LV (1996) Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. Am J Trop Med Hyg 54:526\u2013529","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/3-540-30791-5_6","volume":"296","author":"N Giron\u00e9s","year":"2005","unstructured":"Giron\u00e9s N, Cuervo H, Fresno M (2005) Trypanosoma cruzi-induced molecular mimicry and Chagas\u2019 disease. Curr Top Microbiol Immunol 296:89\u2013123","journal-title":"Curr Top Microbiol Immunol"},{"key":"9211_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-3024.1998.00154.x","volume":"20","author":"S Kumar","year":"1998","unstructured":"Kumar S, Tarleton RL (1998) The relative contribution of antibody production and CD8\u00a0+\u00a0T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20:207\u2013216","journal-title":"Parasite Immunol"},{"key":"9211_CR31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/IAI.64.6.1961-1967.1996","volume":"64","author":"JC Aliberti","year":"1996","unstructured":"Aliberti JC, Cardoso MA, Martins GA, Gazzinelli RT, Vieira LQ, Silva JS (1996) Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophage in response to live trypomastigotes. Infect Immun 64:1961\u20131967","journal-title":"Infect Immun"},{"key":"9211_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0167-5699(96)30069-8","volume":"18","author":"M Fresno","year":"1997","unstructured":"Fresno M, Kopf M, Rivas L (1997) Cytokines and infectious diseases. Immunol Today 18:56\u201358","journal-title":"Immunol Today"},{"key":"9211_CR33","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/eji.1830221006","volume":"22","author":"RT Gazzinelli","year":"1992","unstructured":"Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukibn-10 and transforming growth factor-beta. Eur J Immunol 22:2501\u20132506","journal-title":"Eur J Immunol"},{"key":"9211_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eji.1830220203","volume":"22","author":"MA Munoz-Fernandez","year":"1992","unstructured":"Munoz-Fernandez MA, Fernandez MA, Fresno M (1992) Synergism between tumor necrosis factor\u2013alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 22:301\u2013307","journal-title":"Eur J Immunol"},{"key":"9211_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.175.1.169","volume":"175","author":"JS Silva","year":"1992","unstructured":"Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG (1992) Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 175:169\u2013174","journal-title":"J Exp Med"},{"key":"9211_CR36","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.146.10.3626","volume":"146","author":"F Torrico","year":"1991","unstructured":"Torrico F, Heremans H, Rivera MT, van Marck E, Billiau A, Carlier Y (1991) Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146:3626\u20133632","journal-title":"J Immunol"},{"key":"9211_CR37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/IAI.66.3.1208-1215.1998","volume":"66","author":"C Holscher","year":"1998","unstructured":"Holscher C, Kohler G, Muller U (1998) Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66:1208\u20131215","journal-title":"Infect Immun"},{"key":"9211_CR38","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/IAI.66.6.2960-2968.1998","volume":"66","author":"E Castanos-Velez","year":"1998","unstructured":"Castanos-Velez E, Maerlan S, Osorio LM, Aberg F, Biberfeld P, Orn A, Rottenberg ME (1998) Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun 66:2960\u20132968","journal-title":"Infect Immun"},{"key":"9211_CR39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.0105-2896.2004.00183.x","volume":"201","author":"D Martin","year":"2004","unstructured":"Martin D, Tarleton R (2004) Generation, specificity, and function of CD8\u00a0+\u00a0T cells in Trypanosoma cruzi infection. Immunol Rev 201:304\u2013317","journal-title":"Immunol Rev"},{"key":"9211_CR40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0166-6851(91)90116-N","volume":"48","author":"HA Avila","year":"1991","unstructured":"Avila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L (1991) Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas\u2019 disease. Mol Biochem Parasitol 48:211\u2013221","journal-title":"Mol Biochem Parasitol"},{"key":"9211_CR41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/JCM.34.5.1171-1175.1996","volume":"34","author":"LV Kirchhoff","year":"1996","unstructured":"Kirchhoff LV, Votava JR, Ochs DE, Moser DR (1996) Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J Clin Microbiol 34:1171\u20131175","journal-title":"J Clin Microbiol"},{"key":"9211_CR42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/522181","volume":"45","author":"CL Karp","year":"2007","unstructured":"Karp CL, Auwaerter PG (2007) Coinfection with HIV and Tropical Infectious Diseases. I. Protozoal Pathogens. Clin Infect Dis 45:1208\u20131213","journal-title":"Clin Infect Dis"},{"key":"9211_CR43","first-page":"271","volume":"38","author":"C Mady","year":"1982","unstructured":"Mady C, de Moraes AV, Galiano N, D\u00e9court LV (1982) Hemodynamic study of the indeterminate form of Chagas\u2019 disease. Arq Bras Cardiol 38:271\u2013275","journal-title":"Arq Bras Cardiol"},{"key":"9211_CR44","first-page":"156","volume":"88","author":"RE Sicca","year":"1995","unstructured":"Sicca RE, Gonzalez Cappa SM, Sanz OP, Mirkin G (1995) Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis. Bull Soc Pathol Exot 88:156\u2013163","journal-title":"Bull Soc Pathol Exot"},{"issue":"Suppl 1","key":"9211_CR45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S0074-02761999000700061","volume":"94","author":"ER Lopes","year":"1999","unstructured":"Lopes ER (1999) Sudden death in patients with Chagas disease. Mem Inst Oswaldo Cruz 94(Suppl 1):321\u2013324","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-4894(02)00024-3","volume":"100","author":"LO Andrade","year":"2002","unstructured":"Andrade LO, Machado CR, Chiari E, Pena SD, Macedo AM (2002) Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations. Exp Parasitol 100:269\u2013275","journal-title":"Exp Parasitol"},{"key":"9211_CR47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0065-308X(06)64004-9","volume":"64","author":"M Tibayrenc","year":"2007","unstructured":"Tibayrenc M (2007) Human genetic diversity and the epidemiology of parasitic and other transmissible diseases. Adv Parasitol 64:377\u2013462","journal-title":"Adv Parasitol"},{"key":"9211_CR48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0198-8859(00)00161-0","volume":"61","author":"Z Layrisse","year":"2000","unstructured":"Layrisse Z, Fernandez MT, Montagnani S, Matos M, Balbas O, Herrera F, Colorado IA, Catalioti F, Acquatella H (2000) HLA-C*03 is a risk factor for cardiomyopathy in Chagas disease. Human Immunol 61:925\u2013929","journal-title":"Human Immunol"},{"key":"9211_CR49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/08820130902766589","volume":"38","author":"S Garcia Borras","year":"2009","unstructured":"Garcia Borras S, Racca L, Cotorruelo C, Biondi C, Beloscar J, Racca A (2009) Distribution of HLA-DRB1 alleles in Argentinien patients with Chagas\u2019 disease cardiomyopathy. Immunol Invest 38:268\u2013275","journal-title":"Immunol Invest"},{"key":"9211_CR50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1286-4579(00)00501-3","volume":"2","author":"KC Fae","year":"2000","unstructured":"Fae KC, Drigo SA, Cunha-Neto E, Ianni B, Mady C, Kalil J, Goldberg AC (2000) HLA and \u00df-myosin heavy chain do not influence susceptibility to Chagas\u2019 disease cardiomyopathy. Microbes Infect 2:745\u2013751","journal-title":"Microbes Infect"},{"key":"9211_CR51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0035-9203(03)80016-0","volume":"97","author":"S Yacoub","year":"2003","unstructured":"Yacoub S, Birks EJ, Slavik Z, Henein M (2003) Early detection of myocardial dysfunction in Chagas disease using novel echocardiographic indices. Trans R Soc Trop Med Hyg 97:528\u2013534","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"9211_CR52","first-page":"493","volume":"15","author":"S Dubner","year":"2008","unstructured":"Dubner S, Schapachnik E, Riera AR, Valero E (2008) Chagas disease: state-of-the-art of diagnosis and management. Cardiol J 15:493\u2013504","journal-title":"Cardiol J"},{"key":"9211_CR53","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","volume":"298","author":"C Bern","year":"2007","unstructured":"Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC (2007) Evaluation and treatment of Chags disease in the United States: a systematic review. JAMA 298:2171\u20132181","journal-title":"JAMA"},{"key":"9211_CR54","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/hrt.2003.018960","volume":"90","author":"RJ Viotti","year":"2004","unstructured":"Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, Ruiz Vera B, Armenti H (2004) Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 90:655\u2013660","journal-title":"Heart"},{"key":"9211_CR55","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.106.627323","volume":"115","author":"H Acuatella","year":"2007","unstructured":"Acuatella H (2007) Echocardiography in Chagas heart disease. Circulation 115:1124\u20131131","journal-title":"Circulation"},{"key":"9211_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/RMR.0b013e31816fcb22","volume":"19","author":"ML Shehata","year":"2008","unstructured":"Shehata ML, Turkbey EB, Vogel-Claussen J, Bluemke DA (2008) Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Top Magn Reson Imaging 19:43\u201357","journal-title":"Top Magn Reson Imaging"},{"key":"9211_CR57","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pcad.2009.02.001","volume":"51","author":"HB Tanowitz","year":"2009","unstructured":"Tanowitz HB, Machado FS, Jelicks LA, Shirani J, de Carvalho AC, Spray DC, Factor SM, Kirchhoff LV, Weiss LM (2009) Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 51:524\u2013539","journal-title":"Prog Cardiovasc Dis"},{"key":"9211_CR58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/S0036-46652000000300009","volume":"42","author":"MS Braga","year":"2000","unstructured":"Braga MS, Lauria-Pires L, Arga\u00f1araz ER, Nascimento RJ, Teixeira AR (2000) Persistent infections in chronic Chagas\u2019 disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev Inst Med Trop Sao Paulo 42:157\u2013161","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"9211_CR59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4269\/ajtmh.2000.63.111","volume":"63","author":"L Lauria-Pires","year":"2000","unstructured":"Lauria-Pires L, Braga MS, Vexenat AC, Nitz N, Sim\u00f5es-Barbosa A, Tinoco DL, Teixeira AR (2000) Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am J Trop Med Hyg 63:111\u2013118","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR60","first-page":"199","volume":"71","author":"N Hern\u00e1ndez-Becerril","year":"2001","unstructured":"Hern\u00e1ndez-Becerril N, Nava A, Reyes PA, Monte\u00f3n VM (2001) IgG subclases reactivity to Trypanosoma cruzi in chronic chagasic patients. Arch Cardiol Mex 71:199\u2013205","journal-title":"Arch Cardiol Mex"},{"key":"9211_CR61","first-page":"347","volume":"15","author":"WL Tafuri","year":"1973","unstructured":"Tafuri WL, Maria TA, Lopes ER, Chapadeiro E (1973) Electron microscopy of the myocardium in human trypanosomiasis cruzi. Rev Inst Med Trop Sao Paulo 15:347\u2013370","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"9211_CR62","first-page":"820","volume":"7","author":"MA Rossi","year":"2001","unstructured":"Rossi MA (2001) Connective tissue skeleton in the normal left ventricle and in hypertensive left ventricular hypertrophy and chronic chagasic myocarditis. Med Sci Monit 7:820\u2013832","journal-title":"Med Sci Monit"},{"key":"9211_CR63","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/0002-8703(85)90222-4","volume":"110","author":"JS Oliveira","year":"1985","unstructured":"Oliveira JS (1985) A natural human model of intrinsic heart nervous system denervation: Chagas\u2019 cardiopathy. Am Heart J 110:1092\u20131098","journal-title":"Am Heart J"},{"key":"9211_CR64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1552-6569.2008.00305.x","volume":"19","author":"M Py","year":"2009","unstructured":"Py M, Pedrosa R, Silveira J, Medeiros A, Andre C (2009) Neurological manifestations in Chagas disease without cardiac dysfunction: correlation between dysfunction of the parasympathetic nervous system and white matter lesions in the brain. J Neuroimaging 19:332\u2013336","journal-title":"J Neuroimaging"},{"key":"9211_CR65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1990.43.159","volume":"43","author":"RH Gallerano","year":"1990","unstructured":"Gallerano RH, Marr JJ, Sosa RR (1990) Therapeutic efficacy of allopurinol in patients with chronic Chagas\u2019 disease. Am J Trop Med Hyg 43:159\u2013166","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s000590050017","volume":"25","author":"G Wallukat","year":"2000","unstructured":"Wallukat G, Nissen E, Morwinski R, M\u00fcller J (2000) Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 25:261\u2013266","journal-title":"Herz"},{"key":"9211_CR67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2009.06.064","volume":"55","author":"G Wallukat","year":"2010","unstructured":"Wallukat G, Munoz Saravia GS, Haberland A, Bartel S, Araujo R, Valda G, Duchen D, Diaz Ramirez I, Borges AC, Schimke I (2010) Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas\u2019 cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas\u2019 patients. J Am Coll Cardiol 55:463\u2013468","journal-title":"J Am Coll Cardiol"},{"key":"9211_CR68","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","volume":"35","author":"SB Felix","year":"2000","unstructured":"Felix SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, D\u00f6cke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590\u20131598","journal-title":"J Am Coll Cardiol"},{"key":"9211_CR69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","volume":"101","author":"J M\u00fcller","year":"2000","unstructured":"M\u00fcller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385\u2013391","journal-title":"Circulation"},{"key":"9211_CR70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2249.2007.03381.x","volume":"148","author":"V Labovsky","year":"2007","unstructured":"Labovsky V, Smulski CR, G\u00f3mez K; Levy G, Levin MJ (2007) Anti-beta 1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin Exp Immunol 148:440\u2013449","journal-title":"Clin Exp Immunol"},{"key":"9211_CR71","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2362.2010.02314.x","volume":"40","author":"C Trimpert","year":"2010","unstructured":"Trimpert C, Herda LR, Eckerle LG, Pohle S, M\u00fcller C, Landsberger M, Felix SB, Staudt A (2010) Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J Clin Invest 40:685\u2013691","journal-title":"Eur J Clin Invest"},{"key":"9211_CR72","unstructured":"EP 2197900 (2010, Aug 5) 1-Adrenozeptor-Antik\u00f6rper inhibierende, mutierte, doppeltcyklisierte Rezeptorpeptide"},{"key":"9211_CR73","unstructured":"Haberland A, Wallukat G, Dahmen C, Kage A, Schimke I (2010) JACC (submitted)"},{"key":"9211_CR74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0001-706X(01)00202-9","volume":"81","author":"DM Engman","year":"2002","unstructured":"Engman DM, Leon JS (2002) Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop 81:123\u2013132","journal-title":"Acta Trop"},{"key":"9211_CR75","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08916930500485002","volume":"39","author":"E Cunha-Neto","year":"2006","unstructured":"Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM (2006) Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39:41\u201354","journal-title":"Autoimmunity"},{"key":"9211_CR76","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.150.4.1611","volume":"150","author":"DD Reis","year":"1993","unstructured":"Reis DD, Gazzinelli RT, Gazzinelli G, Colley DG (1993) Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas\u2019 disease. J Immunol 150:1611\u20131618","journal-title":"J Immunol"},{"key":"9211_CR77","first-page":"7","volume-title":"G-protein coupled receptors and autoantibodies","author":"G Wallukat","year":"2002","unstructured":"Wallukat G, Nissen E, M\u00fcller J, Brinckmann R, Schimke I, Kunze R (2002) The pathophysiological role of autoantibodies directed to G-protein coupled receptors and therapeutic strategies of antibody removal. In: Brinckmann R, Kunze R (eds) G-protein coupled receptors and autoantibodies. Pabst Science Publishers, Legerich, pp 7\u201347"},{"key":"9211_CR78","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.4049\/jimmunol.157.9.4203","volume":"157","author":"R Elies","year":"1996","unstructured":"Elies R, Ferrari I, Wallukat G, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J, Levin MJ (1996) Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas\u2019 disease. J Immunol 157:4203\u20134211","journal-title":"J Immunol"},{"key":"9211_CR79","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1096\/fasebj.12.14.1551","volume":"12","author":"MO Masuda","year":"1998","unstructured":"Masuda MO, Levin M, De Oliveira SF, Dos Santos Costa PC, Bergami PL, Dos Santos Almeida NA, Pedrosa RC, Ferrari I, Hoebeke J, Campos de Carvalho AC (1998) Functionally active cardiac antibodies in chronic Chagas\u2019 disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J 12:1551\u20131558","journal-title":"FASEB J"},{"key":"9211_CR80","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S0893-133X(00)00153-6","volume":"23","author":"PR Gouldson","year":"2000","unstructured":"Gouldson PR, Higgs C, Smith RE, Dean MK, Gkoutos GV, Reynolds CA (2000) Dimerization and domain swapping in G-protein-coupled receptors: a computational study. Neuropsychopharmacology 23:S60\u2013S77","journal-title":"Neuropsychopharmacology"},{"key":"9211_CR81","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/08916930802031702","volume":"41","author":"MJ Levin","year":"2008","unstructured":"Levin MJ, Hoebeke J (2008) Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas\u2019 heart disease. Autoimmunity 41:429\u2013433","journal-title":"Autoimmunity"},{"key":"9211_CR82","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","volume":"113","author":"R Jahns","year":"2004","unstructured":"Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419\u20131429","journal-title":"J Clin Invest"},{"key":"9211_CR83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2006.05.008","volume":"112","author":"R Jahns","year":"2006","unstructured":"Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7\u201314","journal-title":"Int J Cardiol"},{"key":"9211_CR84","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1432-1327.1998.2510659.x","volume":"251","author":"R Elies","year":"1998","unstructured":"Elies R, Fu LX, Eftekhari P, Wallukat G, Schulze W, Granier C, Hjalmarson A, Hoebeke J (1998) Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor. Eur J Biochem 251:659\u2013666","journal-title":"Eur J Biochem"},{"key":"9211_CR85","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1006\/jmcc.2001.1414","volume":"33","author":"T Christ","year":"2001","unstructured":"Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U (2001) Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33:1515\u20131525","journal-title":"J Mol Cell Cardiol"},{"key":"9211_CR86","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.103.13.1765","volume":"103","author":"PA Chiale","year":"2000","unstructured":"Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, Levin MJ (2000) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103:1765\u20131771","journal-title":"Circulation"},{"key":"9211_CR87","first-page":"349","volume":"74","author":"L Sterin-Borda","year":"1988","unstructured":"Sterin-Borda L, Perez Leiros C, Wald M, Cremaschi G, Borda E (1988) Antibodies to beta 1 beta 2 adrenoreceptors in Chagas\u2019 disease. Clin Exp Immunol 74:349\u2013354","journal-title":"Clin Exp Immunol"},{"key":"9211_CR88","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0735-1097(00)00881-0","volume":"36","author":"R Jahns","year":"2000","unstructured":"Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 36:1280\u20131287","journal-title":"J Am Coll Cardiol"},{"key":"9211_CR89","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/01.CIR.89.6.2760","volume":"89","author":"Y Magnusson","year":"1994","unstructured":"Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of autoantibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89:2760\u20132767","journal-title":"Circulation"},{"key":"9211_CR90","first-page":"37","volume":"3","author":"EG Krause","year":"1996","unstructured":"Krause EG, Bartel S, Beyerdorfer I, Wallukat G (1996) Activation of cyclic AMP-dependent protein kinase in cardiomyocytes by anti-beta 1-adrenoceptor autoantibodies from patients with idiopathic dilated cardiomyopathy. Blood Press Suppl 3:37\u201340","journal-title":"Blood Press Suppl"},{"key":"9211_CR91","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1126\/science.280.5367.1271","volume":"280","author":"CE Ford","year":"1998","unstructured":"Ford CE, Skiba NP, Bae H, Daaka Y, Reuveny E, Shekter LR, Rosal R, Weng G, Yang CS, Iyengar R, Miller RJ, Jan LY, Lefkowitz RJ, Hamm HE (1998) Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280:1271\u20131274","journal-title":"Science"},{"key":"9211_CR92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fasebj.11.1.9034169","volume":"11","author":"JC Goin","year":"1997","unstructured":"Goin JC, Leiros CP, Borda E, Sterin-Borda L (1997) Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 11:77\u201383","journal-title":"FASEB J"},{"key":"9211_CR93","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0016-5085(99)70337-9","volume":"117","author":"JC Goin","year":"1999","unstructured":"Goin JC, Sterin-Borda L, Bilder CR, Varrica LM, Iantorno G, R\u00edos MC, Borda E (1999) Functional implications of circulatin muscarinic cholinergic receptor autoantibodies in Chagasic patients with achalasia. Gastroenterology 117:798\u2013805","journal-title":"Gastroenterology"},{"key":"9211_CR94","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/gut.49.5.699","volume":"49","author":"L Sterin-Borda","year":"2001","unstructured":"Sterin-Borda L, Goin JC, Bilder CR, Iantorno G, Hernando AC, Borda E (2001) Interaction of human chagasic IgG with human colon muscar\u00ednico acetylcholine receptor: molecular and functional evidence. Gut 49:699\u2013705","journal-title":"Gut"},{"key":"9211_CR95","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1074\/jbc.272.20.12989","volume":"272","author":"CP Leiros","year":"1997","unstructured":"Leiros CP, Sterin-Borda L, Borda ES, Goin JC, Hosey MM (1997) Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas\u2019 disease. J Biol Chem 272:12989\u201312993","journal-title":"J Biol Chem"},{"key":"9211_CR96","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1590\/S0037-86822008000600011","volume":"41","author":"AY Pinto","year":"2008","unstructured":"Pinto AY, Valente SA, Valente Vda C, Ferreira Junior AG, Coura JR (2008) Acute phase of Chagas disease in the Brazilian Amazon region: study of 233 cases from Par\u00e1, Amap\u00e1 and Maranh\u00e3o observed between 1988 and 2005. Rev Soc Bras Med Trop 41:602\u2013614","journal-title":"Rev Soc Bras Med Trop"},{"key":"9211_CR97","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4269\/ajtmh.1992.46.616","volume":"46","author":"C Diaz","year":"1992","unstructured":"Diaz C, Nussenzweig V, Gonzalez A (1992) An improved polymerase chain reaction assay to detect Trypanosoma cruzi in blood. Am J Trop Med Hyg 46:616\u2013623","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR98","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(05)64761-7","volume":"348","author":"AR Vago","year":"1996","unstructured":"Vago AR, Macedo AM, Adad SJ, Reis DD, Corr\u00eaa-Oliveira R (1996) PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas\u2019 disease. Lancet 348:891\u2013892","journal-title":"Lancet"},{"key":"9211_CR99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1537-2995.2009.02107.x","volume":"49","author":"MM Otani","year":"2009","unstructured":"Otani MM, Vinelli E, Kirchhoff LV, del Pozo A, Sands A, Vercauteren G, Sabino EC (2009) WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 49:1076\u20131082","journal-title":"Transfusion"},{"key":"9211_CR100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/1566524043360249","volume":"4","author":"DA Campbell","year":"2004","unstructured":"Campbell DA, Westenberger SJ, Sturm NR (2004) The determinants of Chagas disease: connecting parasite and host genetics. Curr Mol Med 4:549\u2013562","journal-title":"Curr Mol Med"},{"key":"9211_CR101","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2010.02.057","volume":"56","author":"SG Munoz Saravia","year":"2010","unstructured":"Munoz Saravia SG, Haberland A, Bartel S, Araujo R, Valda G, Duchen D, Diaz Ramirez I, Borges AC, Wallukat G, Schimke I (2010) Distinct patterns of autoantibodies against G-protein coupled receptors in Chagas\u2019 cardiomyopathy and megacolon: their potential impact for early risk assessment in asymptomatic Chagas\u2019 patients. J Am Coll Cardiol 56:526\u2013527","journal-title":"J Am Coll Cardiol"},{"key":"9211_CR102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.82.3.273","volume":"82","author":"JC Goin","year":"1999","unstructured":"Goin JC, Borda E, Auger R, Storino R, Sterni-Borda L (1999) Cardiac M(2) muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia. Heart 82:273\u2013278","journal-title":"Heart"},{"key":"9211_CR103","first-page":"S634","volume":"46","author":"G Wallukat","year":"1987","unstructured":"Wallukat G, Wollenberger A (1987) Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chromotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta 46:S634\u2013S639","journal-title":"Biomed Biochim Acta"},{"key":"9211_CR104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1025469515963","volume":"251","author":"G Wallukat","year":"2003","unstructured":"Wallukat G, Podlowski S, Nissen E, Morwinski R, Csonka C, Tosaki A, Blasig IE (2003) Functional and structural characterization of anti-beta1-adrenoceptor autoantibodies of spontaneously hypertensive rats. Mol Cell Biochem 251:67\u201375","journal-title":"Mol Cell Biochem"},{"key":"9211_CR105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2007.03.051","volume":"50","author":"VO Nikolaev","year":"2007","unstructured":"Nikolaev VO, Boivin V, St\u00f6rk S, Angermann CE, Ertl G, Lohse MJ, Jahns R (2007) A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 50:423\u2013431","journal-title":"J Am Coll Cardiol"},{"key":"9211_CR106","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","volume":"99","author":"R Jahns","year":"1999","unstructured":"Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F (1999) Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99:649\u2013654","journal-title":"Circulation"},{"key":"9211_CR107","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0002-8703(92)90704-Y","volume":"123","author":"CJ Limas","year":"1992","unstructured":"Limas CJ, Goldenberg IF, Limas C (1992) Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors. Am Heart J 123:967\u2013970","journal-title":"Am Heart J"},{"key":"9211_CR108","doi-asserted-by":"crossref","first-page":"H1928","DOI":"10.1152\/ajpheart.00044.2004","volume":"287","author":"C Del Corsso","year":"2004","unstructured":"Del Corsso C, de Carvalho AC, Martino HF, Varanda WA (2004) Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits. Am J Physiol Heart Circ Physiol 287:H1928\u2013H1936","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9211_CR109","first-page":"73","volume":"47","author":"L Cervetta","year":"2002","unstructured":"Cervetta L, Moretti E, Basso B (2002) Experimental Chagas\u2019 disease: the protection induced by immunization with Trypanosoma rangeli is associated with down-regulation of IL-6, TNF-\u03b1 and IL-10 synthesis. Acta Parasitol 47:73\u201378","journal-title":"Acta Parasitol"},{"key":"9211_CR110","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1128\/IAI.60.9.3904-3908.1992","volume":"60","author":"DR Pakianathan","year":"1992","unstructured":"Pakianathan DR, Kuhn RE (1992) Interleukin-2 receptors in experimental Chagas\u2019 disease. Infect Immun 60:3904\u20133908","journal-title":"Infect Immun"},{"key":"9211_CR111","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4269\/ajtmh.1996.54.154","volume":"54","author":"N Medrano-Mercado","year":"1996","unstructured":"Medrano-Mercado N, Luz MR, Torrico F, Tapia G, Van Leuven F, Araujo-Jorge TC (1996) Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia. Am J Trop Med Hyg 54:154\u2013161","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR112","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/tropej\/42.2.68","volume":"42","author":"NM Medrano","year":"1996","unstructured":"Medrano NM, Luz MR, Cabello PH, Tapia GT, Van Leuven F, Ara\u00fajo-Jorge TC (1996) Acute Chagas\u2019 disease: plasma levels of alpha-2-macroglobulin and C-reactive protein in children under 13\u00a0years in a high endemic area of Bolivia. J Trop Pediatr 42:68\u201374","journal-title":"J Trop Pediatr"},{"key":"9211_CR113","first-page":"184","volume":"16","author":"JM Pascale","year":"1991","unstructured":"Pascale JM, Sousa CE, Orn A (1991) Evaluation of interleukin-2 soluble receptor in patients with tripanosomiasis Americana in Panama. Rev Med Panama 16:184\u2013188","journal-title":"Rev Med Panama"},{"key":"9211_CR114","first-page":"12","volume":"17","author":"JM Pascale","year":"1992","unstructured":"Pascale JM, Sousa OE, Orn A (1992) Determination of soluble interleukin-2 receptor in patients with American trypanosomiasis in Panama. Rev Med Panama 17:12\u201316","journal-title":"Rev Med Panama"},{"key":"9211_CR115","first-page":"1324","volume":"9","author":"E Moretti","year":"2002","unstructured":"Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G (2002) Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagas\u2019 disease. Clin Diagn Lab Immunol 9:1324\u20131327","journal-title":"Clin Diagn Lab Immunol"},{"key":"9211_CR116","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/503368","volume":"193","author":"R Ramasawmy","year":"2006","unstructured":"Ramasawmy R, Cunha-Neto E, Fa\u00e9 KC, M\u00fcller NG, Cavalcanti VL, Drigo SA, Ianni B, Mady C, Kalil J, Goldberg AC (2006) BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis 193:1394\u20131399","journal-title":"J Infect Dis"},{"key":"9211_CR117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1157\/13083649","volume":"59","author":"L L\u00f3pez","year":"2006","unstructured":"L\u00f3pez L, Arai K, Gim\u00e9nez E, Jim\u00e9nez M, Pascuzo C, Rodr\u00edguez-Bonfante C, Bonfante-Cabarcas R (2006) C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure. Rev Esp Cardiol 59:50\u201356","journal-title":"Rev Esp Cardiol"},{"key":"9211_CR118","doi-asserted-by":"crossref","unstructured":"Munoz Saravia SG, Haberland A, Bartel S, Araujo R, Valda G, Duchen D, Diaz Ramirez I, Borges AC, Wallukat G, Schimke I (2010) Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas\u2019 disease. Arch Pathol Lab Med (in press)","DOI":"10.5858\/135.2.243"},{"key":"9211_CR119","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4269\/ajtmh.1993.49.370","volume":"49","author":"MS Cetron","year":"1993","unstructured":"Cetron MS, Basilio FP, Moraes AP, Sousa AQ, Paes JN, Kahn SJ, Wener MH, Van Voorhis WC (1993) Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas\u2019 disease patients with symptomatic versus indeterminate infection. Am J Trop Med Hyg 49:370\u2013382","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ejheart.2004.10.014","volume":"7","author":"AO Mocelin","year":"2005","unstructured":"Mocelin AO, Issa VS, Bacal F, Guimar\u00e3es GV, Cunha E, Bocchi EA (2005) The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas\u2019 heart disease and idiopathic dilated cardiomyopathy. Eur J Heart Fail 7:869\u2013873","journal-title":"Eur J Heart Fail"},{"key":"9211_CR121","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0074-02762003000300021","volume":"98","author":"RC Ferreira","year":"2003","unstructured":"Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, Cunha-Neto E (2003) Increased plasma levels of tumor necrosis factor-alpha in asymptomatic\/\u201dindeterminate\u201d and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98:407\u2013411","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1179\/136485907X154593","volume":"101","author":"R P\u00e9rez-Fuentes","year":"2007","unstructured":"P\u00e9rez-Fuentes R, L\u00f3pez-Colombo A, Ord\u00f3\u00f1ez-Toquero G, Gomez-Albino I, Ramos J, Torres-Rasgado E, Salgado-Rosas H, Romero-D\u00edaz M, Pulido-P\u00e9rez P, S\u00e1nchez-Guill\u00e9n MC (2007) Correlation of the serum concentrations of tumour necrosis factor and nitric oxide with disease severity in chronic Chagas disease (American trypanosomiasis). Ann Trop Med Parasitol 101:123\u2013132","journal-title":"Ann Trop Med Parasitol"},{"key":"9211_CR123","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1086\/381892","volume":"38","author":"A Talvani","year":"2004","unstructured":"Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM (2004) Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38:943\u2013950","journal-title":"Clin Infect Dis"},{"key":"9211_CR124","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1590\/S0037-86822005000600007","volume":"38","author":"DB Rodrigues","year":"2005","unstructured":"Rodrigues DB, Correia D, Marra MD, Giraldo LE, Lages-Silva E, Silva-Vergara ML, Barata CH (2005) Rodrigues Junior V (2005) Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection. Rev Soc Bras Med Trop 38:483\u2013487","journal-title":"Rev Soc Bras Med Trop"},{"key":"9211_CR125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","volume":"52","author":"I Dalle-Donne","year":"2006","unstructured":"Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52:601\u2013623","journal-title":"Clin Chem"},{"key":"9211_CR126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10408360903142326","volume":"46","author":"D Giustarini","year":"2009","unstructured":"Giustarini D, Dalle-Donne I, Tsikas D, Rossi R, Giustarini D (2009) Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46:241\u2013281","journal-title":"Crit Rev Clin Lab Sci"},{"key":"9211_CR127","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500\u2013508","journal-title":"J Clin Invest"},{"key":"9211_CR128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijcard.2006.04.046","volume":"116","author":"TB Oliveira de","year":"2007","unstructured":"de Oliveira TB, Pedrosa RC, Filho DW (2007) Oxidative stress in chronic cardiopathy associated with Chagas\u2019 disease. Int J Cardiol 116:357\u2013363","journal-title":"Int J Cardiol"},{"key":"9211_CR129","doi-asserted-by":"crossref","unstructured":"Gupta S, Wen JJ, Garg NJ (2009) Oxidative stress in Chagas disease. Interdiscip Perspect Infect Dis 190354 [Epub 2009, Jun 14]","DOI":"10.1155\/2009\/190354"},{"key":"9211_CR130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2006.11.118","volume":"123","author":"LB Ma\u00e7ao","year":"2007","unstructured":"Ma\u00e7ao LB, Wilhelm Filho D, Pedrosa RC, Pereira A, Backes P, Torres MA, Fr\u00f6de TS (2007) Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas\u2019 disease. Int J Cardiol 123:43\u201349","journal-title":"Int J Cardiol"},{"key":"9211_CR131","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.131.3.1504","volume":"131","author":"F Villalta","year":"1983","unstructured":"Villalta F, Kierszenbaum F (1983) Role of polymorphonuclear cells in Chagas\u2019 disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human neutrophils. J Immunol 131:1504\u20131510","journal-title":"J Immunol"},{"key":"9211_CR132","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jlb.56.6.672","volume":"56","author":"JA Smith","year":"1994","unstructured":"Smith JA (1994) Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 56:672\u2013686","journal-title":"J Leukoc Biol"},{"key":"9211_CR133","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(00)00481-2","volume":"109","author":"BM Babior","year":"2000","unstructured":"Babior BM (2000) Phagocytes and oxidative stress. Am J Med 109:33\u201344","journal-title":"Am J Med"},{"key":"9211_CR134","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.micinf.2008.06.013","volume":"10","author":"JJ Wen","year":"2008","unstructured":"Wen JJ, Dhiman M, Whorton EB, Garg NJ (2008) Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice. Microbes Infect 10:1201\u20131209","journal-title":"Microbes Infect"},{"key":"9211_CR135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2008.09.014","volume":"120","author":"AL B\u00e1ez","year":"2008","unstructured":"B\u00e1ez AL, Lo Presti MS, Rivarola HW, Pons P, Fretes R, Paglini-Oliva P (2008) Trypanosoma cruzi: cardiac mitochondrial alterations produced by different strains in the acute phase of the infection. Exp Parasitol 120:397\u2013402","journal-title":"Exp Parasitol"},{"key":"9211_CR136","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2353\/ajpath.2006.060475","volume":"169","author":"JJ Wen","year":"2006","unstructured":"Wen JJ, Bhatia V, Popov VL, Garg NJ (2006) Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas\u2019 disease. Am J Pathol 169:1953\u20131964","journal-title":"Am J Pathol"},{"key":"9211_CR137","first-page":"795","volume":"20","author":"PE Palhares","year":"1987","unstructured":"Palhares PE, Marcondes NS, Fontana J\u00fanior P, Schaeffer GM, Bastos OM (1987) Correlation between tissue damage and malondialdehydemia in mice infected with Trypanosoma cruzi. Braz J Med Biol Res 20:795\u2013798","journal-title":"Braz J Med Biol Res"},{"key":"9211_CR138","first-page":"799","volume":"20","author":"PE Palhares","year":"1987","unstructured":"Palhares PE, Marcondes NS, Fontana J\u00fanior P, Schaeffer GM, Bastos OM (1987) Malondialdehydemia and parasitemia during acute phase of experimental Chagas\u2019 disease in mice. Braz J Med Biol Res 20:799\u2013801","journal-title":"Braz J Med Biol Res"},{"key":"9211_CR139","first-page":"957","volume":"21","author":"PE Palhares","year":"1988","unstructured":"Palhares PE, Fontana J\u00fanior P, Schaffer GM, Marcondes NS, Vergara M (1988) Tissue damage markers in experimental Chagas\u2019 disease. Braz J Med Biol Res 21:957\u2013959","journal-title":"Braz J Med Biol Res"},{"key":"9211_CR140","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.freeradbiomed.2004.08.018","volume":"37","author":"JJ Wen","year":"2004","unstructured":"Wen JJ, Vyatkina G, Garg N (2004) Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic Biol Med 37:1821\u20131833","journal-title":"Free Radic Biol Med"},{"key":"9211_CR141","first-page":"884","volume":"10","author":"Y Michowitz","year":"2008","unstructured":"Michowitz Y, Kisil S, Guzner-Gur H, Rubinstein A, Wexler D, Sheps D, Keren G, George J (2008) Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure. Isr Med Assoc J 10:884\u2013888","journal-title":"Isr Med Assoc J"},{"key":"9211_CR142","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CVI.00019-09","volume":"16","author":"M Dhiman","year":"2009","unstructured":"Dhiman M, Estrada-Franco JG, Pando JM, Ramirez-Aguilar FJ, Spratt H, Vazquez-Corzo S, Perez-Molina G, Gallegos-Sandoval R, Moreno R, Garg NJ (2009) Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas\u2019 disease. Clin Vaccine Immunol 16:660\u2013666","journal-title":"Clin Vaccine Immunol"},{"key":"9211_CR143","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2006.04.009","volume":"41","author":"JJ Wen","year":"2006","unstructured":"Wen JJ, Yachelini PC, Sembaj A, Manzur RE, Garg NJ (2006) Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients. Free Radic Biol Med 41:270\u2013276","journal-title":"Free Radic Biol Med"},{"key":"9211_CR144","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0020-7519(02)00283-7","volume":"33","author":"R P\u00e9rez-Fuentes","year":"2003","unstructured":"P\u00e9rez-Fuentes R, Gu\u00e9gan JF, Barnab\u00e9 C, L\u00f3pez-Colombo A, Salgado-Rosas H, Torres-Rasgado E, Briones B, Romero-D\u00edaz M, Ramos-Jim\u00e9nez J, S\u00e1nchez-Guill\u00e9n Mdel C (2003) Severity of chronic Chagas disease is associated with cytokine\/antioxidant imbalance in chronically infected individuals. Int J Parasitol 33:293\u2013299","journal-title":"Int J Parasitol"},{"key":"9211_CR145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1179\/136485908X267858","volume":"102","author":"R P\u00e9rez-Fuentes","year":"2008","unstructured":"P\u00e9rez-Fuentes R, Torres-Rasgado E, Salgado-Rosas H, Zamora-Ginez I, S\u00e1nchez-Guill\u00e9n MC (2008) The anti-oxidant defence response in individuals with the indeterminate form of Chagas disease (American trypanosomiasis). Ann Trop Med Parasitol 102:189\u2013197","journal-title":"Ann Trop Med Parasitol"},{"key":"9211_CR146","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4269\/ajtmh.2002.66.706","volume":"66","author":"MT Rivera","year":"2002","unstructured":"Rivera MT, de Souza AP, Moreno AH, Xavier SS, Gomes JA, Rocha MO, Correa-Oliveira R, N\u00e8ve J, Vanderpas J, Ara\u00fajo-Jorge TC (2002) Progressive Chagas\u2019 cardiomyopathy is associated with low selenium levels. Am J Trop Med Hyg 66:706\u2013712","journal-title":"Am J Trop Med Hyg"},{"key":"9211_CR147","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","volume":"10","author":"A Maisel","year":"2008","unstructured":"Maisel A, Mueller C, Adams K et al (2008) State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 10:824\u2013839","journal-title":"Eur J Heart Fail"},{"key":"9211_CR148","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(02)09638-1","volume":"360","author":"AL Ribeiro","year":"2002","unstructured":"Ribeiro AL, dos Reis AM, Barros MV, de Sousa MR, Rocha AL, Perez AA, Pereira JB, Machado FS, Rocha MO (2002) Brain natriuretic peptide and left ventricular dysfunction in Chagas\u2019 disease. Lancet 360:461\u2013462","journal-title":"Lancet"},{"key":"9211_CR149","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1590\/S0074-02762004000600020","volume":"99","author":"A Talvani","year":"2004","unstructured":"Talvani A, Rocha MO, Cogan J, Maewal P, de Lemos J, Ribeiro AL, Teixeira MM (2004) Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy. Mem Inst Oswaldo Cruz 99:645\u2013649","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9211_CR150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ijcard.2004.06.007","volume":"100","author":"A Talvani","year":"2005","unstructured":"Talvani A, Rocha MO, Cogan J, Maewal P, de Lemos J, Ribeiro AL, Teixeira MM (2005) Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia. Int J Cardiol 100:503\u2013504","journal-title":"Int J Cardiol"},{"key":"9211_CR151","first-page":"137","volume":"84","author":"RB Melo","year":"2005","unstructured":"Melo RB, Parente GB, Victor EG (2005) Measurement of human brain natriuretic peptide in patients with Chagaws disease. Arq Bras Cardiol 84:137\u2013140","journal-title":"Arq Bras Cardiol"},{"key":"9211_CR152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1751-7133.2008.08166.x","volume":"14","author":"F Vilas-Boas","year":"2008","unstructured":"Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Nascimento T, Barojas MM, Andrade MV, Ribeiro-Dos-Santos R, Bocchi E (2008) Invasive and noninvasive correlations of B-type natriuretic peptide in patients with heart failure due to Chagas cardiomyopathy. Congest Heart Fail 14:121\u2013126","journal-title":"Congest Heart Fail"},{"key":"9211_CR153","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/S0066-782X2006001600017","volume":"87","author":"DS Marques","year":"2006","unstructured":"Marques DS, Canesin MF, Barutta J\u00fanior F, Fuganti CJ, Barretto AC (2006) Evaluation of asymptomatic patients with chronic Chagas disease through ambulatory electrocardiogram, echocardiogram and B-Type natriuretic peptide analyses. Arq Bras Cardiol 87:336\u2013343","journal-title":"Arq Bras Cardiol"},{"key":"9211_CR154","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/hrt.2003.026856","volume":"91","author":"S Heringer-Walther","year":"2005","unstructured":"Heringer-Walther S, Moreira MC, Wessel N, Saliba JL, Silvia-Barra J, Pena JL, Becker S, Siems WE, Schultheiss HP, Walther T (2005) Brain natriuretic peptide predicts survival in Chagas\u2019 disease more effectively than atrial natriuretic peptide. Heart 91:385\u2013387","journal-title":"Heart"},{"key":"9211_CR155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000112403","volume":"110","author":"C Moreira Mda","year":"2008","unstructured":"Moreira Mda C, Heringer-Walther S, Wessel N, Moreira Ventura T, Wang Y, Schultheiss HP, Walther T (2008) Prognostic value of natriuretic peptides in Chagas\u2019 disease: a 3-year follow-up investigation. Cardiology 110:217\u2013225","journal-title":"Cardiology"},{"key":"9211_CR156","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2005.05.048","volume":"109","author":"AL Ribeiro","year":"2006","unstructured":"Ribeiro AL, Teixeira MM, Reis AM, Talvani A, Perez AA, Barros MV, Rocha MO (2006) Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. Int J Cardiol 109:34\u201340","journal-title":"Int J Cardiol"},{"key":"9211_CR157","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2007.01.034","volume":"125","author":"L Sousa","year":"2008","unstructured":"Sousa L, Botoni FA, Britto RR, Rocha MO, Teixeira AL Jr, Teixeira MM, Reis AM, Oliveira BM, Ribeiro AL (2008) Six-minute walk test in Chagas cardiomyopathy. Int J Cardiol 125:139\u2013141","journal-title":"Int J Cardiol"},{"key":"9211_CR158","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1540-8175.2009.01081.x","volume":"27","author":"MM Lima","year":"2010","unstructured":"Lima MM, Nunes MC, Rocha MO, Beloti FR, Alencar MC, Ribeiro AL (2010) Left ventricular diastolic function and exercise capacity in patients with chagas cardiomyopathy. Echocardiography 27:519\u2013524","journal-title":"Echocardiography"},{"key":"9211_CR159","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1540-8175.2008.00842.x","volume":"26","author":"BM Oliveira","year":"2009","unstructured":"Oliveira BM, Botoni FA, Ribeiro AL, Pinto AS, Reis AM, Nunes Mdo C, Rocha MO (2009) Correlation between BNP levels and Doppler echocardiographic parameters of left ventricle filling pressure in patients with Chagasic cardiomyopathy. Echocardiography 26:521\u2013527","journal-title":"Echocardiography"},{"key":"9211_CR160","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1590\/S0100-879X2006005000152","volume":"40","author":"F Fernandes","year":"2007","unstructured":"Fernandes F, Dantas S, Ianni BM, Ramires FJ, Buck P, Salemi VM, Lopes HF, Mady C (2007) Leptin levels in different forms of Chagas\u2019 disease. Braz J Med Biol Res 40:1631\u20131636","journal-title":"Braz J Med Biol Res"},{"key":"9211_CR161","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.euje.2006.03.011","volume":"8","author":"MM Barbosa","year":"2007","unstructured":"Barbosa MM, Nunes Mdo C, Ribeiro AL, Barral MM, Rocha MO (2007) N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. Eur J Echocardiogr 8:204\u2013212","journal-title":"Eur J Echocardiogr"},{"key":"9211_CR162","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0066-782X2008001300008","volume":"91","author":"C Mady","year":"2008","unstructured":"Mady C, Fernandes F, Arteaga E, Ramires FJ, Buck Pde C, Salemi VM, Ianni BM, Nastari L, Dias RR (2008) Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies. ArQ Bras Cardiol 91:46\u201350","journal-title":"ArQ Bras Cardiol"},{"key":"9211_CR163","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pcad.2004.07.004","volume":"47","author":"BM Scirica","year":"2004","unstructured":"Scirica BM, Morrow DA (2004) Troponins in acute coronary syndromes. Prog Cardiovasc Dis 47:177\u2013188","journal-title":"Prog Cardiovasc Dis"},{"key":"9211_CR164","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1373\/clinchem.2008.106427","volume":"55","author":"A Mingels","year":"2009","unstructured":"Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M (2009) Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 55:101\u2013108","journal-title":"Clin Chem"},{"key":"9211_CR165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/CT:1:2:087","volume":"1","author":"AS Jaffe","year":"2001","unstructured":"Jaffe AS (2001) Elevation in cardiac troponin measurements: false false-positives. Cardiovasc Toxicol 1:87\u201392","journal-title":"Cardiovasc Toxicol"},{"key":"9211_CR166","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-142-9-200505030-00015","volume":"142","author":"A Jeremias","year":"2005","unstructured":"Jeremias A, Gibson CM (2005) Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 142:786\u2013791","journal-title":"Ann Intern Med"},{"key":"9211_CR167","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1373\/clinchem.2006.071498","volume":"52","author":"O Schulz","year":"2006","unstructured":"Schulz O, Kirpal K, Stein J, Bensch R, Bergh\u00f6fer G, Schimke I, Jaffe AS (2006) Importance of low concentrations of cardiac troponins. Clin Chem 52:1614\u20131615","journal-title":"Clin Chem"},{"key":"9211_CR168","first-page":"51","volume":"56","author":"SG Saravia","year":"2010","unstructured":"Saravia SG, Knebel F, Schroeckh S, Ziebig R, Lun A, Weimann A, Haberland A, Borges AC, Schimke I (2010) Cardiac troponin T release and inflammation demonstrated in marathon runners. Clin Lab 56:51\u201358","journal-title":"Clin Lab"},{"key":"9211_CR169","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1157\/13049658","volume":"56","author":"AL Basquiera","year":"2003","unstructured":"Basquiera AL, Capra R, Omelianiuk M, Amuch\u00e1stegui M, Madoery RJ, Salomone OA (2003) Serum troponin T in patients with chronic Chagas disease. Rev Esp Cardiol 56:742\u2013744","journal-title":"Rev Esp Cardiol"},{"key":"9211_CR170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/S1413-86702003000600001","volume":"7","author":"R Arias","year":"2003","unstructured":"Arias R, Bastos C, Mota G, Sodr\u00e9 F, Moreira A, Tavares A, Lima JC (2003) Troponin in Chagas disease. Braz J Infect Dis 7:358\u2013359","journal-title":"Braz J Infect Dis"},{"key":"9211_CR171","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/S0066-782X2005000200019","volume":"84","author":"MN Machado","year":"2005","unstructured":"Machado MN, Suzuki FA, Mouco OC, Hernandes ME, Lemos MA, Maia LN (2005) Positive troponin T in a chagasic patient with sustained ventricular tachycardia and no obstructive lesions on cine coronary angiography. Arq Bras Cardiol 84:182\u2013184","journal-title":"Arq Bras Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-010-9211-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-010-9211-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-010-9211-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T02:46:26Z","timestamp":1712025986000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-010-9211-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,17]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["9211"],"URL":"https:\/\/doi.org\/10.1007\/s10741-010-9211-5","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,17]]}}}